Condition
Mild Concussion
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06244472Not ApplicableRecruitingPrimary
A New Generation of Magnetoencephalographs for High Speed Functional Brain Imaging
NCT01814527Not ApplicableCompletedPrimary
High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
NCT02171312CompletedPrimary
Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool
Showing all 3 trials